Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Accumulated OCI
-$4.47M
Quarterly · Period ending: · USD
LCTX Accumulated OCI
Latest reported-$4.47Mperiod ending
Latest reported-$4.47Mperiod ending
LCTX Quarterly Accumulated OCI ($0.00 → -$4.47M)
Quarterly accumulated oci
High-resolution chart · PNG
LCTX accumulated oci history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Accumulated OCI (USD) |
|---|---|
| -4,473,000 | |
| -7,942,000 | |
| -3,920,000 | |
| -4,286,000 | |
| -4,098,000 | |
| -2,681,000 | |
| -2,876,000 | |
| -2,890,000 | |
| -2,470,000 | |
| -2,771,000 | |
| -3,068,000 | |
| -2,084,000 | |
| -2,611,000 | |
| -3,107,000 | |
| -3,571,000 | |
| -3,184,000 | |
| -3,357,000 | |
| -5,087,000 | |
| -5,211,000 | |
| -3,433,000 | |
| -3,051,000 | |
| -2,091,000 | |
| -3,667,000 | |
| -821,000 | |
| -486,000 | |
| 634,000 | |
| -681,000 | |
| -357,000 | |
| 207,000 | |
| 694,000 | |
| 1,426,000 | |
| 1,174,000 | |
| 1,082,000 | |
| 198,000 | |
| 451,000 | |
| 141,000 | |
| 271,000 | |
| 408,000 | |
| -738,000 | |
| -690,000 | |
| -504,000 | |
| -60,000 | |
| -237,000 | |
| -87,000 | |
| -131,000 | |
| 238,820 | |
| 185,835 | |
| -150,691 | |
| -85,134 | |
| -44,341 | |
| 62,899 | |
| 124,740 | |
| 117,724 | |
| 88,867 | |
| -59,570 | |
| -197,384 | |
| -181,607 | |
| 1,340 | |
| -122,749 | |
| -99,488 | |
| -701,204 | |
| 227,333 | |
| 897,338 | |
| -2,363 | |
| -5,910 | |
| -64,711 | |
| -54,291 | |
| -626,122 | |
| -618,926 | |
| -610,662 | |
| -602,510 | |
| -594,506 | |
| -588,318 | |
| -586,995 | |
| -585,765 | |
| -585,047 | |
| -584,165 | |
| -582,690 | |
| -580,933 | |
| -580,314 | |
| -579,977 | |
| -576,394 | |
| -574,931 | |
| -573,837 | |
| -572,982 | |
| -568,557 | |
| -568,557 | |
| -562,885 | |
| -554,492 | |
| -543,982 | |
| -532,663 | |
| -516,771 | |
| -505,753 | |
| -493,098 | |
| -478,396 | |
| -458,670 | |
| -442,852 | |
| -426,192 | |
| -409,331 | |
| -396,517 |